Phytopharm PLC
27 November 2003
Re: Notification of Major Interests in Shares
The Company received notification on 27th November 2003 from AMVESCAP PLC
concerning the realignment of interests in the Company's shares. Following the
recent conversion of unit trusts to ICVCs, AMVESCAP ceased to be interested,
within the meaning of Sections 203 and 208 of the Act, in 6,238,803 ordinary
shares. Immediately following this transaction, AMVESCAP had a notifiable
interest in 4,002,059 (10.3%) shares. The breakdown of AMVESCAP's registered
holders are set out below:
Registered Holder Number of Shares
Bank of New York Nominees Limited 618,918
Chase Nominees Limited 342,000
Vidacos Nominees Limited 1,309,764
HSBC Nominees Limited 1,514,427
Northern Trust Nominees Limited 210,000
CM Investment Nominees Limited 6,950
Immediately following the same transaction, the ICVC and registered holder named
below had a notifiable interest in the following number of shares:
ICVC Registered Holder Number of Shares %
INVESCO Perpetual UK Vidacos Nominees 5,406,647 13.9
Investment Series Limited
AMVESCAP's aggregate holding remains unchanged at 10,240,862 shares (26.4%) as
disclosed on 2 June 2003, following transfers between the funds under its
management.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.